Juan Quevedo

860 total citations
7 papers, 39 citations indexed

About

Juan Quevedo is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, Juan Quevedo has authored 7 papers receiving a total of 39 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Medicine, 4 papers in Applied Microbiology and Biotechnology and 3 papers in Pharmacology. Recurrent topics in Juan Quevedo's work include Antibiotic Resistance in Bacteria (4 papers), Antibiotic Use and Resistance (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Juan Quevedo is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antibiotic Use and Resistance (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Juan Quevedo collaborates with scholars based in Spain, United States and Italy. Juan Quevedo's co-authors include Anne Santerre Henriksen, Laurent Dortet, Rémy A. Bonnin, Rafael Cantón, N. Dunkel, Ian Morrissey, J.-F. Timsit, Stephen Hawser, Marie Attwood and Keith S. Kaye and has published in prestigious journals such as Clinical Microbiology and Infection, International Journal of Antimicrobial Agents and Future Microbiology.

In The Last Decade

Juan Quevedo

7 papers receiving 38 citations

Peers

Juan Quevedo
Juan Quevedo
Citations per year, relative to Juan Quevedo Juan Quevedo (= 1×) peers María Teresa Pérez-Rodríguez

Countries citing papers authored by Juan Quevedo

Since Specialization
Citations

This map shows the geographic impact of Juan Quevedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Quevedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Quevedo more than expected).

Fields of papers citing papers by Juan Quevedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Quevedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Quevedo. The network helps show where Juan Quevedo may publish in the future.

Co-authorship network of co-authors of Juan Quevedo

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Quevedo. A scholar is included among the top collaborators of Juan Quevedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Quevedo. Juan Quevedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wagenlehner, Flo ri an, et al.. (2025). Efficacy of treatment options for complicated urinary tract infections including acute pyelonephritis: a systematic literature review and network meta-analysis. Journal of Comparative Effectiveness Research. 14(3). e240214–e240214. 2 indexed citations
2.
Novales, Francisco Javier Membrillo de, Marco Falcone, Àlex Soriano, et al.. (2025). Safety of ceftobiprole in patients with impaired renal, hepatic or immune function: A multinational retrospective hospital chart review (RETRACE study). International Journal of Antimicrobial Agents. 65(4). 107450–107450. 1 indexed citations
3.
Bhowmick, Tanaya, Rafael Cantón, Federico Pea, et al.. (2025). Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales. Future Microbiology. 20(4). 277–286. 7 indexed citations
4.
Morrissey, Ian, Stephen Hawser, N. Dunkel, et al.. (2024). Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates. Journal of Global Antimicrobial Resistance. 38. 71–82. 6 indexed citations
5.
Bonnin, Rémy A., et al.. (2024). In vitro activity of cefepime-enmetazobactam on carbapenem-resistant Gram negatives. Clinical Microbiology and Infection. 31(2). 240–249. 13 indexed citations
6.
Cantón, Rafael, et al.. (2022). In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016–19). JAC-Antimicrobial Resistance. 4(2). dlac030–dlac030. 5 indexed citations
7.
Yarzebski, Jorge, Robert J. Goldberg, M. Carmen González, et al.. (2012). Gender disparities in Puerto Ricans hospitalized with an initial acute myocardial infarction: A population-based perspective.. PubMed. 31(4). 192–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026